FXH Fact Sheet: First Trust Health Care AlphaDEX Fund
Share
$133.43
close, Nov 18, 2026
Over the year to Nov 18, 2026, FXH returned +20.0% in total and charged 0.61% a year.
- 1-year total return
- +20.0%
- to Nov 18, 2026
- Expense ratio
- 0.61%
- a year
- Net assets
- $1.2bn
- on Nov 17, 2026
- Net flow, last 5 trading days
- +$6.7m
- daily basis to Nov 17, 2026
Growth of $10,000, 1 year
FXH $12,000 +20.0% · IWB $11,170 +11.7% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month+0.8%
3 months−0.9%
Year to date+17.8%
1 year+20.0%
3 years+43.4%
5 years+12.5%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
Centene Corporation2.69%
Zimmer Biomet Holdings, Inc.2.65%
Universal Health Services, Inc. (Class B)2.54%
The Cigna Group2.50%
Medpace Holdings, Inc.2.41%
Regeneron Pharmaceuticals, Inc.2.33%
GE HealthCare Technologies Inc.2.31%
Eli Lilly and Company2.26%
Solventum Corporation2.25%
Zoetis Inc.2.21%
FXH top ten by weight, 24.1% of the fund, of its 72 equity positions, from the holdings published by its issuer for Nov 17, 2026.
Facts
Equity fund · Tracks the StrataQuant Health Care Index · First traded May 10, 2007 · Benchmark Its own holdings, as of Nov 17, 2026